Follow-up Study to Previous CARE Trial

Completed

Conditions studied: Moderate to Severe Chronic Kidney Disease

In brief

To determine comparative 1-year outcomes in renally impaired patients who previously underwent cardiac angiography with Isovue®-370 or Visipaque™ 320 as part of the IOP-104 trial protocol and were evaluable for determination of post-contrast significant renal injury (defined as \>25% increase in SCr or \>25% increase in cystatin C).

Key facts

Study ID

NCT00479024

Run by

Bracco Diagnostics, Inc

People needed

294

Starts

2007-06-01

Expected to finish

2008-04-01

Last updated by the study team

2009-09-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may not qualify if…

• • Screening eGFR outside the range of 20 and 59 mL/min/1.73m2
• Unstable kidney disease or requiring dialysis upon enrollment
• Prior to the post-dose blood draw, suffered a critical clinical event that would affect the reliability of serological measurement of renal function
• Did not receive randomized contrast agent per CARE protocol
• Did not undergo a cardiac angiography procedure per CARE protocol

Where it is running

• Cardiovascular Associates — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.